rs398122965

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM5PP3_ModeratePP5_Very_Strong

The NM_001199107.2(TBC1D24):​c.724C>T​(p.Arg242Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R242H) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

TBC1D24
NM_001199107.2 missense

Scores

10
6
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10O:1

Conservation

PhyloP100: 3.90
Variant links:
Genes affected
TBC1D24 (HGNC:29203): (TBC1 domain family member 24) This gene encodes a protein with a conserved domain, referred to as the TBC domain, characteristic of proteins which interact with GTPases. TBC domain proteins may serve as GTPase-activating proteins for a particular group of GTPases, the Rab (Ras-related proteins in brain) small GTPases which are involved in the regulation of membrane trafficking. Mutations in this gene are associated with familial infantile myoclonic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM1
In a domain Rab-GAP TBC (size 215) in uniprot entity TBC24_HUMAN there are 17 pathogenic changes around while only 3 benign (85%) in NM_001199107.2
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-2496873-G-A is described in Lovd as [Likely_pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.897
PP5
Variant 16-2496872-C-T is Pathogenic according to our data. Variant chr16-2496872-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 91395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2496872-C-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBC1D24NM_001199107.2 linkuse as main transcriptc.724C>T p.Arg242Cys missense_variant 2/8 ENST00000646147.1 NP_001186036.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBC1D24ENST00000646147.1 linkuse as main transcriptc.724C>T p.Arg242Cys missense_variant 2/8 NM_001199107.2 ENSP00000494678 A1Q9ULP9-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
249378
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135348
show subpopulations
Gnomad AFR exome
AF:
0.0000646
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000884
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1461768
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
10
AN XY:
727198
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000153
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152228
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000882
Hom.:
0
Bravo
AF:
0.0000756
ExAC
AF:
0.00000825
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DOORS syndrome Pathogenic:4Other:1
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGM-The missense variant p.R242C in TBC1D24 (NM_001199107.2) has been reported previously in affected individuals with DOORS syndrome (Campeau PM et al). Functional studies reveal a damaging effect (Balestrini S et al). The variant has been submitted to ClinVar as Pathogenic. The p.R242C variant is observed in 1/15,478 (0.0065%) alleles from individuals of African background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a large physicochemical difference between arginine and cysteine, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. The p.R242C missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 242 of TBC1D24 is conserved in all mammalian species. The nucleotide c.724 in TBC1D24 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2014- -
Pathogenic, no assertion criteria providedliterature onlyDivision of Medical Genetics; Sainte-Justine HospitalDec 22, 2014- -
Pathogenic, criteria provided, single submitterresearchLupski Lab, Baylor-Hopkins CMG, Baylor College of MedicineJan 01, 2014We identified 26 families with DOORS syndrome; each patient had at least 3 of the 5 well-described features of DOORS syndrome, which include deafness, onychodystrophy, osteodystrophy, intellectual disability, and seizures. A combination of whole-exome sequencing and Sanger sequencing identified homozygous or compound heterozygous pathogenic variants in TBC1D24 in 11 individuals from 9 families. -
not provided, no classification providedliterature onlyGeneReviews-- -
Developmental and epileptic encephalopathy, 16 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLaboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert EinsteinMay 10, 2021ACMG classification criteria: PS3 supporting, PS4 moderate, PM2 moderate, PM3 strong, PP3 supporting -
Likely pathogenic, criteria provided, single submitterclinical testingNeuroMeGen, Hospital Clinico Santiago de CompostelaJan 01, 2018- -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsNov 16, 2018The p.R242C pathogenic mutation (also known as c.724C>T), located in coding exon 1 of the TBC1D24 gene, results from a C to T substitution at nucleotide position 724. The arginine at codon 242 is replaced by cysteine, an amino acid with highly dissimilar properties. This mutation was identified in the homozgous and compound heterozygous states in multiple individuals with DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome) (Campeau PM et al. Lancet Neurol, 2014 Jan;13:44-58). Two cell lines expressing this mutation demonstrated shorter neurite length compared to wild type (Balestrini S et al. Neurology, 2016 Jul;87:77-85; Finelli MJ et al. Hum. Mol. Genet., 2018 Oct; doi.org/10.1093/hmg/ddy370). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
TBC1D24-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 20, 2023The TBC1D24 c.724C>T variant is predicted to result in the amino acid substitution p.Arg242Cys. This variant was reported in the compound heterozygous or homozygous state in multiple individuals with DOORS syndrome (Campeau et al. 2014. PubMed ID: 24291220; Balestrini et al. 2016. PubMed ID: 27281533; Fernández-Marmiesse et al. 2019. PubMed ID: 31780880). This variant is reported in 0.0065% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-2546873-C-T). This variant is interpreted as likely pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxJul 03, 2024Published functional studies involving neuronal outgrowth assays of mouse cortical cells demonstrate a reduction in neurite length compared to wild-type (PMID: 27281533); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25169651, 24291220, 27281533, 28428906, 30579089, 31780880, 36147510, 31440721, 30335140) -
Developmental and epileptic encephalopathy, 1;C3892048:Autosomal dominant nonsyndromic hearing loss 65;CN236805:Caused by mutation in the TBC1 domain family, member 24 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 242 of the TBC1D24 protein (p.Arg242Cys). This variant is present in population databases (rs398122965, gnomAD 0.007%). This missense change has been observed in individuals with autosomal recessive TBC1D24-related conditions (PMID: 24291220, 31780880). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 91395). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TBC1D24 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects TBC1D24 function (PMID: 27281533). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.32
.;T;T;.;.;.;.
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.99
.;.;D;D;D;D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.90
D;D;D;D;D;D;D
MetaSVM
Benign
-0.62
T
MutationAssessor
Uncertain
2.7
M;M;M;.;.;M;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-7.9
D;.;D;.;.;.;D
REVEL
Pathogenic
0.86
Sift
Pathogenic
0.0
D;.;D;.;.;.;D
Sift4G
Pathogenic
0.0
D;.;D;.;.;D;D
Polyphen
1.0
D;D;D;.;.;D;.
Vest4
0.99
MutPred
0.72
Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);Loss of MoRF binding (P = 0.0041);
MVP
0.81
MPC
1.3, 1.7
ClinPred
0.98
D
GERP RS
4.2
Varity_R
0.83
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs398122965; hg19: chr16-2546873; COSMIC: COSV53546090; COSMIC: COSV53546090; API